Researchers want to understand how weight loss might affect cancer growth, hormones, metabolism and the immune system, for people who have a high risk of cancer recurrence
1 Owing to the awareness of these complications and important interplay between obesity and diabetes, there has been a recent shift in the development of both glucose-lowering therapies and specific guidelines for managing obesity in patients with T2D in order to improve outcomes and glycemic control
Recommended dose: 1 sachet per day
Proc Natl Acad Sci U S A9436213626
These include: Hypertension or high blood pressure High cholesterol Osteoarthritis Obstructive sleep apnoea Asthma/COPD Non-alcoholic fatty liver disease Polycystic ovarian syndrome Some people may be eligible with a slightly lower BMI, for example those from certain ethnicities including those of Asian, Chinese, Middle Eastern, Black African or African-Caribbean origin